NCT04820179 2026-01-07Atezolizumab + Cabozantinib in Patients w/ Metastatic, Refractory Pancreatic CancerUniversity of ArizonaPhase 2 Active not recruiting30 enrolled
NCT06390059 2025-04-30EF-39 PANOVA-4: Study of Tumor Treating Fields Concomitant With Atezolizumab, Gemcitabine and Nab-Paclitaxel as First-LineTreatment for Metastatic Pancreatic Ductal AdenocarcinomaNovoCure Ltd.Phase 2 Active not recruiting84 enrolled